1. Home
  2. CORT vs FLS Comparison

CORT vs FLS Comparison

Compare CORT & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$95.41

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$72.31

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
FLS
Founded
1998
1790
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.7B
IPO Year
2001
2006

Fundamental Metrics

Financial Performance
Metric
CORT
FLS
Price
$95.41
$72.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
$96.50
$86.00
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
1.04%
EPS Growth
N/A
23.36
EPS
N/A
0.64
Revenue
$761,407,000.00
N/A
Revenue This Year
$26.08
$6.80
Revenue Next Year
$26.98
$6.22
P/E Ratio
N/A
$111.97
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$48.71
52 Week High
$97.05
$92.41

Technical Indicators

Market Signals
Indicator
CORT
FLS
Relative Strength Index (RSI) 63.30 51.61
Support Level $76.41 $69.10
Resistance Level N/A $73.83
Average True Range (ATR) 4.17 2.43
MACD -0.36 0.26
Stochastic Oscillator 81.02 74.97

Price Performance

Historical Comparison
CORT
FLS

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

Share on Social Networks: